Evidence map›Paper›PMID 28332311›Full record

ArticleMicrobiologyOpen2017

Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli.

Courtney M Abana, John R Brannon, Rebecca A Ebbott, Taryn L Dunigan, Kirsten R Guckes, Hubaida Fuseini, Jennifer Powers, Bridget R Rogers, Maria Hadjifrangiskou

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The impact of sublethal antimicrobial blue light on lipidomic changes ofFrontiers in cellular and infection microbiology · 2025
    Article
  9. Inactivation of dried cells and biofilms ofApplied and environmental microbiology · 2023
    Article
  10. Review
  11. Riboflavin- and chlorophyllin-based antimicrobial photoinactivation ofFrontiers in cellular and infection microbiology · 2022
    Article
  12. Blue Light InhibitsFrontiers in microbiology · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Blue Light Is a Universal Signal forJournal of bacteriology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Courtney M AbanaDepartment of Chemical & Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-2734-5928
John R BrannonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Rebecca A EbbottDepartment of Biological Sciences, Vanderbilt University, Nashville, TN, USA.
Taryn L DuniganDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Kirsten R GuckesDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Hubaida FuseiniDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jennifer PowersVanderbilt Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bridget R RogersDepartment of Chemical & Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Maria HadjifrangiskouDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-4249-8997

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
NCATS NIH HHS UL1 TR000445NIGMS NIH HHS R25 GM062459
6 · The paper itself

Abstract

Blue light irradiation (BLI) is an FDA-approved method for treating certain types of infections, like acne, and is becoming increasingly attractive as an antimicrobial strategy as the prevalence of antibiotic-resistant "superbugs" rises. However, no study has delineated the effectiveness of BLI throughout different bacterial growth phases, especially in more BLI-tolerant organisms such as Escherichia coli. While the vast majority of E. coli strains are nonpathogenic, several E. coli pathotypes exist that cause infection within and outside the gastrointestinal tract. Here, we compared the response of E. coli strains from five phylogenetic groups to BLI with a 455 nm wavelength (BLI

Indexed as

LightAdenosine TriphosphateColony Count, MicrobialEscherichia coliMicrobial ViabilityAdenosine TriphosphateE. colimembranespathogenesispersisters

Identifiers

PMID28332311
PMCPMC5552948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.